Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US Food and Drug Administration (FDA) ...
Durable complete responses with CAR-NK + Rituximab in patients who failed current standards of care in Waldenstrom’s ...
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today ...
Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease ...
Critical Access Hospital IT, clinical, and financial users cite repackaged health-system solutions, misaligned implementation ...
The Board of Directors of Sensient Technologies Corporation (NYSE: SXT) has declared a regular quarterly cash dividend on its ...
Pro Forma Revenue Expected to exceed $20M (~4x 2024 Revenue)Wattbike Air-Pro Sells 700+ Units / ~$2.5M in UK Commercial ...
Ombudsman’s investigation triggers review of cancer treatment wait times at NHS Trust An investigation by England’s Health ...
Portal Innovations announced continued growth at Portal Atlanta at Science Square, with the addition of seven new member ...
Lowers the barrier to SPR by reducing sample requirements to microliter scale – up to 99% less material than traditional ...
FillPoint Health, a URAC- and ACHC-accredited specialty pharmacy and management services organization (MSO) and a Lyceum ...
FutureWise Research, a global leader in healthcare market intelligence and analysis, today announced the release of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback